144 related articles for article (PubMed ID: 12046849)
1. Post-transduction events in retrovirus-mediated gene therapy involving hematopoietic stem cells: beyond efficiency issues.
Medin JA; Fowler DH
J Cell Biochem Suppl; 2002; 38():46-54. PubMed ID: 12046849
[TBL] [Abstract][Full Text] [Related]
2. Correction of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapy.
Ting-De Ravin SS; Kennedy DR; Naumann N; Kennedy JS; Choi U; Hartnett BJ; Linton GF; Whiting-Theobald NL; Moore PF; Vernau W; Malech HL; Felsburg PJ
Blood; 2006 Apr; 107(8):3091-7. PubMed ID: 16384923
[TBL] [Abstract][Full Text] [Related]
3. Retroviral Transduction of Quiescent Murine Hematopoietic Stem Cells.
Park CS; Lacorazza HD
Methods Mol Biol; 2018; 1686():173-182. PubMed ID: 29030821
[TBL] [Abstract][Full Text] [Related]
4. Retroviral transduction of murine and human hematopoietic progenitors and stem cells.
Ciuculescu MF; Brendel C; Harris CE; Williams DA
Methods Mol Biol; 2014; 1185():287-309. PubMed ID: 25062637
[TBL] [Abstract][Full Text] [Related]
5. Current status of retroviral vector mediated gene transfer into human hematopoietic stem cells.
Elwood NJ; Smith CA
Leuk Lymphoma; 2001 Mar; 41(1-2):1-18. PubMed ID: 11342353
[TBL] [Abstract][Full Text] [Related]
6. Retroviral vector interactions with hematopoietic cells.
Everson EM; Trobridge GD
Curr Opin Virol; 2016 Dec; 21():41-46. PubMed ID: 27521874
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for severe combined immunodeficiencies.
Gaspar HB; Thrasher AJ
Expert Opin Biol Ther; 2005 Sep; 5(9):1175-82. PubMed ID: 16120048
[TBL] [Abstract][Full Text] [Related]
8. Issues in the manufacture and transplantation of genetically modified hematopoietic stem cells.
Sadelain M; Frassoni F; Rivière I
Curr Opin Hematol; 2000 Nov; 7(6):364-77. PubMed ID: 11055510
[TBL] [Abstract][Full Text] [Related]
9. Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial.
Schmidt M; Hacein-Bey-Abina S; Wissler M; Carlier F; Lim A; Prinz C; Glimm H; Andre-Schmutz I; Hue C; Garrigue A; Le Deist F; Lagresle C; Fischer A; Cavazzana-Calvo M; von Kalle C
Blood; 2005 Apr; 105(7):2699-706. PubMed ID: 15585650
[TBL] [Abstract][Full Text] [Related]
10. Transduction of murine hematopoietic stem cells and in vivo selection of gene-modified cells.
Ide LM; Javazon E; Spencer HT
Methods Mol Biol; 2008; 433():213-28. PubMed ID: 18679626
[TBL] [Abstract][Full Text] [Related]
11. Transduction of long-term-engrafting human hematopoietic stem cells by retroviral vectors.
Porada CD; Tran ND; Almeida-Porada G; Glimp HA; Pixley JS; Zhao Y; Anderson WF; Zanjani ED
Hum Gene Ther; 2002 May; 13(7):867-79. PubMed ID: 11975852
[TBL] [Abstract][Full Text] [Related]
12. Murine hematopoietic stem cell transduction using retroviral vectors.
Modlich U; Schambach A; Li Z; Schiedlmeier B
Methods Mol Biol; 2009; 506():23-31. PubMed ID: 19110617
[TBL] [Abstract][Full Text] [Related]
13. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells.
Benjelloun F; Garrigue A; Demerens-de Chappedelaine C; Soulas-Sprauel P; Malassis-Séris M; Stockholm D; Hauer J; Blondeau J; Rivière J; Lim A; Le Lorc'h M; Romana S; Brousse N; Pâques F; Galy A; Charneau P; Fischer A; de Villartay JP; Cavazzana-Calvo M
Mol Ther; 2008 Aug; 16(8):1490-9. PubMed ID: 18560421
[TBL] [Abstract][Full Text] [Related]
14. Progress toward vector design for hematopoietic stem cell gene therapy.
Hawley RG
Curr Gene Ther; 2001 May; 1(1):1-17. PubMed ID: 12109133
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer of adenosine deaminase into primitive human hematopoietic progenitor cells.
Cournoyer D; Scarpa M; Mitani K; Moore KA; Markowitz D; Bank A; Belmont JW; Caskey CT
Hum Gene Ther; 1991; 2(3):203-13. PubMed ID: 1751590
[TBL] [Abstract][Full Text] [Related]
16. Efficient bone marrow transduction by gene transfer with allogeneic umbilical cord blood serum and plasma: an implication for clinical trials.
Moon N; Yang SJ; Park BB; Chung YS; Lee JW; Oh IH
Hum Gene Ther; 2008 Jul; 19(7):744-52. PubMed ID: 18557700
[TBL] [Abstract][Full Text] [Related]
17. [Transplantation of genetically modified cells in the treatment of children with SCID: great hopes and recent disappointments].
Smogorzewska EM; Weinberg KI; Kohn DB
Med Wieku Rozwoj; 2003; 7(1):27-34. PubMed ID: 13130167
[TBL] [Abstract][Full Text] [Related]
18. The third conference on hematopoietic stem cell gene therapy: biology and technology.
Emery DW; Bodine DM
Mol Ther; 2002 Jun; 5(6):658-63. PubMed ID: 12027548
[No Abstract] [Full Text] [Related]
19. Hematopoietic stem cells expanded by fibroblast growth factor-1 are excellent targets for retrovirus-mediated gene delivery.
Crcareva A; Saito T; Kunisato A; Kumano K; Suzuki T; Sakata-Yanagimoto M; Kawazu M; Stojanovic A; Kurokawa M; Ogawa S; Hirai H; Chiba S
Exp Hematol; 2005 Dec; 33(12):1459-69. PubMed ID: 16338488
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for primary immunodeficiencies.
Fischer A; Hacein-Bey Abina S; Touzot F; Cavazzana M
Clin Genet; 2015 Dec; 88(6):507-15. PubMed ID: 25708106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
